Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVO

Recent news which mentions NVO

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
What Are Pfizer's Prospects In Obesity Pill Market? Analysts Say Optimism, Cautiousness Surround With Data Awaited Next Year
Tickers LLY NVO PFE
Tags LLY NVO PFE
From Benzinga
Is There Room for Improvement In Weight Loss Arena? Analysts Evaluate Novo Nordisk Data, Emphasize Opportunities for Eli Lilly
Tickers LLY NVO
Tags Large Cap Biotech Health Care
From Benzinga
Diabetes stocks are surprise winners from Novo Nordisk’s Wegovy study, analysts say
Tickers DVA DXCM ISRG NVO
Tags DVA NVO ISRG
From MarketWatch
What's Going On With Novo Nordisk Stock Today?
Tickers NVO
Tags General Movers News
From Benzinga
Big Players' Recent Trades in NVO Options
Tickers NVO
Tags NVO Options Benzinga
From Benzinga
The Magnificent Seven: 7 Stocks That Could Make It the ‘Elite Eight’
Tickers AMD BRK-A BRK-B INTC
Tags TSM AMD JPM
From InvestorPlace
Morgan Stanley has boosted its S&P 500 target — but here’s where it sees the real opportunities
Tickers AAPL AMC AMZN BA
Tags SPX NQ00 NVDA
From MarketWatch
Better Buy Now: Novo Nordisk vs. Eli Lilly
Tickers JNJ LLY NVO PFE
Tags LLY NVO Recent Press Releases
From Motley Fool
Wegovy Weight Loss Drug Cuts Heart Complication Risk, Says Trial
Tickers LLY NVO
Tags General Biotech News
From Benzinga
'Market's Had A Very Solid Winning Streak Of Late': Jim Cramer Eyes Key Retailers And CPI Data In Critical Earnings Week Ahead
Tickers ACN CRM HD LLY
Tags TGT Equities WMT
From Benzinga
Novo Nordisk’s Wegovy cuts risk of heart attack and stroke by 20% among people without diabetes, study finds
Tickers LLY NVO SPX
Tags SPX LLY NVO
From MarketWatch
Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth
Tickers JNJ LLY NVO
Tags JNJ Market News NVO
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV BBIO DXCM LLY
Tags NVO LLY BBIO
From Benzinga
Here’s how Eli Lilly might bring a game-changing Alzheimer’s drug to market
Tickers AAPL AMZN ARM CART
Tags DJIA NVDA MSFT
From MarketWatch
3 Stocks to Buy for Retirees Looking to Beat Inflation
Tickers BRK-A BRK-B FICO LLY
Tags NYSE:BRK/A,NYSE:BRK/B,NYSE:FICO,NYSE:LLY,NYSE:NVO BRK/A FICO
From InvestorPlace
Who’s afraid of Ozempic? From restaurants to package makers, companies work to calm investors’ GLP-1 jitters.
Tickers ABT AZN BUD CCK
Tags ABT FMS CCK
From MarketWatch
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Tickers ASTR COIN GAN LLY
Tags ASTR COIN $BTC
From Benzinga
Novo Nordisk, maker of Ozempic and Wegovy, to invest more than $6 billion to expand production
Tickers NVO SPX
Tags SPX NVO
From MarketWatch
Widely Popular GLP-1-Based Weight Loss Drugs Reshape US Healthcare Landscape, May Help Control Addiction
Tickers LLY NVO WBA
Tags News Briefs WBA
From Benzinga
'I Want You To Buy It, And Every Time It Dips, I Want You To Buy More': Cramer Hypes Up Auto Parts Retailer
Tickers A AEHR AVGO AZO
Tags DFH SNOW Small Cap
From Benzinga
Could Novo Nordisk Stock Help You Retire a Millionaire?
Tickers NVO
Tags NVO Recent Press Releases Market News
From Motley Fool
Novo Nordisk Seeks Obesity, Diabetes 'Bolt-On' Deals As It Beefs Up Capacity To Meet Soaring Demand
Tickers NVO
Tags Benzinga NVO Market News
From Benzinga
7 Biotech Stocks to Buy for Big-Time Gains
Tickers BGNE EXAS ICAD LLY
Tags Stocks to Buy Market News MRK
From InvestorPlace
The Stock-Split Stock Behind Ozempic and Wegovy Could Be Yours for Just $100
Tickers LLY NVO
Tags Market News NVO LLY
From Motley Fool
Look Out, Ozempic and Wegovy: Eli Lilly Has a New Weight-Loss Drug in Town
Tickers LLY NVO PFE
Tags Market News LLY NVO
From Motley Fool
Lilly's Strategic Branding Move For Weight Loss Drug Sets Stage For Long Term Success - Analyst
Tickers LLY NVO
Tags Movers Briefs News
From Benzinga
Eli Lilly Has Yet Another Ozempic Killer in the Works. Is It a Screaming Buy?
Tickers LLY NVO
Tags NVO LLY Recent Press Releases
From Motley Fool
Novo Nordisk Ceases Production Of One Long-Acting Insulin In US Amid Manufacturing Constraints, Competition
Tickers NVO
Tags NVO Benzinga Market News
From Benzinga
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
Tickers NVO
Tags Recent Press Releases NVO Market News
From Motley Fool
Weight Loss Drug Competition - FDA Approves Expanded Use Of Eli Lilly's Blockbuster Tirzepatide For Weight Loss, Undercutting Novo Nordisk's Price
Tickers LLY NVO
Tags Biotech Large Cap Health Care
From Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.